Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafiou Agoro

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Frontiers in Endocrinology|September 28, 2020
Osteocytic FGF23 and Its Kidney FunctionRafiou Agoro, Pu Ni, Megan L Noonan, et al.
Cell Reports|January 27, 2021
Identification of a second Klotho interaction site in the C terminus of FGF23Archita Agrawal, Pu Ni, Rafiou Agoro, et al.
Plos One|December 12, 2024
Phosphorus-independent role of FGF23 in erythropoiesis and iron homeostasisMin Young Park, Rafiou Agoro, Stanislovas S Jankauskas, et al.
Haematologica|March 21, 2020
C-FGF23 peptide alleviates hypoferremia during acute inflammationRafiou Agoro, Min Young Park, Carole Le Henaff, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 27, 2018
Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemiaRafiou Agoro, Anna Montagna, Regina Goetz, et al.
The Journal of Infectious Diseases|October 4, 2017
An Iron-Rich Diet Decreases the Mycobacterial Burden and Correlates With Hepcidin Upregulation, Lower Levels of Proinflammatory Mediators, and Increased T-Cell Recruitment in a Model of Mycobacterium bovis Bacille Calmette-Guerin InfectionRafiou Agoro, Sulayman Benmerzoug, Stéphanie Rose, et al.
Physiological Reports|June 2, 2020
Erythropoietin and a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHDi) lowers FGF23 in a model of chronic kidney disease (CKD)Megan L Noonan, Erica L Clinkenbeard, Pu Ni, et al.
Physiological Reports|June 3, 2022
Segregating the effects of ferric citrate-mediated iron utilization and FGF23 in a mouse model of CKDMichael P Liesen, Megan L Noonan, Pu Ni, et al.
Endocrinology|August 30, 2025
Interindividual genetic differences drive discordance between serum calcidiol and calcitriol concentrations in femalesElizabeth K Hutchins, Changran Niu, Jing Xue, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 16, 2021
The HIF-PHI BAY 85-3934 (Molidustat) Improves Anemia and Is Associated With Reduced Levels of Circulating FGF23 in a CKD Mouse ModelMegan L Noonan, Pu Ni, Rafiou Agoro, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Frontiers in Endocrinology|September 28, 2020
Osteocytic FGF23 and Its Kidney FunctionRafiou Agoro, Pu Ni, Megan L Noonan, et al.
Cell Reports|January 27, 2021
Identification of a second Klotho interaction site in the C terminus of FGF23Archita Agrawal, Pu Ni, Rafiou Agoro, et al.
Plos One|December 12, 2024
Phosphorus-independent role of FGF23 in erythropoiesis and iron homeostasisMin Young Park, Rafiou Agoro, Stanislovas S Jankauskas, et al.
Haematologica|March 21, 2020
C-FGF23 peptide alleviates hypoferremia during acute inflammationRafiou Agoro, Min Young Park, Carole Le Henaff, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 27, 2018
Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemiaRafiou Agoro, Anna Montagna, Regina Goetz, et al.
The Journal of Infectious Diseases|October 4, 2017
An Iron-Rich Diet Decreases the Mycobacterial Burden and Correlates With Hepcidin Upregulation, Lower Levels of Proinflammatory Mediators, and Increased T-Cell Recruitment in a Model of Mycobacterium bovis Bacille Calmette-Guerin InfectionRafiou Agoro, Sulayman Benmerzoug, Stéphanie Rose, et al.
Physiological Reports|June 2, 2020
Erythropoietin and a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHDi) lowers FGF23 in a model of chronic kidney disease (CKD)Megan L Noonan, Erica L Clinkenbeard, Pu Ni, et al.
Physiological Reports|June 3, 2022
Segregating the effects of ferric citrate-mediated iron utilization and FGF23 in a mouse model of CKDMichael P Liesen, Megan L Noonan, Pu Ni, et al.
Endocrinology|August 30, 2025
Interindividual genetic differences drive discordance between serum calcidiol and calcitriol concentrations in femalesElizabeth K Hutchins, Changran Niu, Jing Xue, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 16, 2021
The HIF-PHI BAY 85-3934 (Molidustat) Improves Anemia and Is Associated With Reduced Levels of Circulating FGF23 in a CKD Mouse ModelMegan L Noonan, Pu Ni, Rafiou Agoro, et al.
Pageof 3